ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation (Q53389043)
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation |
scientific article published in March 2002 |
Statements
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation (English)
Frank T Kolligs
Marvin T Nieman
Ira Winer
Gang Hu
David Van Mater
Ying Feng
Ian M Smith
Rong Wu
Yali Zhai
Kathleen R Cho
Eric R Fearon
1 March 2002
1
2
145-155